Skip to main content
logo
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.45
+0.15 (1.33%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Artiva Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.2533.494.932
Revenue Growth
---99.25%579.21%146.30%-
Gross Profit
--0.2533.494.932
Selling, General & Admin
20.2920.2717.2113.9120.7812.86
Research & Development
75.8669.5450.3350.2543.9842.41
Operating Expenses
96.1589.8167.5364.1664.7655.27
Operating Income
-96.15-89.81-67.28-30.67-59.83-53.27
Interest & Investment Income
5.335.965.352.541.29-
Other Non Operating Income (Expenses)
-1.89-1.89-5.78-0.97-0.2-18.55
EBT Excluding Unusual Items
-92.7-85.75-67.72-29.1-58.74-71.83
Gain (Loss) on Sale of Investments
1.881.882.340.46--
Pretax Income
-90.82-83.87-65.37-28.65-58.74-71.83
Income Tax Expense
---0.070.05-
Net Income
-90.82-83.87-65.37-28.72-58.79-71.83
Net Income to Common
-90.82-83.87-65.37-28.72-58.79-71.83
Net Income Growth
------
Shares Outstanding (Basic)
282411111
Shares Outstanding (Diluted)
282411111
Shares Change
22.89%117.11%1302.54%4.70%11.80%8.60%
EPS (Basic)
-3.21-3.43-5.81-35.78-76.67-104.73
EPS (Diluted)
-3.21-3.43-5.81-35.78-76.67-104.73
EPS Growth
------
Free Cash Flow
-76.91-79.34-55.67-50.69-57.13-17.03
Free Cash Flow Per Share
-2.72-3.25-4.95-63.14-74.51-24.83
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---26805.58%-91.58%-1213.32%-2660.94%
Profit Margin
---26045.02%-85.75%-1192.21%-3587.66%
Free Cash Flow Margin
---22180.88%-151.34%-1158.55%-850.55%
EBITDA
-93.46-87.21-64.85-28.41-58.67-53.02
EBITDA Margin
----84.81%--
D&A For EBITDA
2.692.62.432.271.160.25
EBIT
-96.15-89.81-67.28-30.67-59.83-53.27
EBIT Margin
----91.58%--
Revenue as Reported
---33.494.93-
SEC Filings: 10-K · 10-Q